High-end Cellomics Market to be worth USD 536.9 Mn by 2031, Get Insights FMI

According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031. High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small …

Needle-Free Injectors Market to cross USD 42.79 Billion by 2032, Says Future Market Insights

The global needle-free injectors market is likely to accumulate value of US$ 13.78 Billion in 2022, and is expected to reach US$ 42.79 Billion by registering a CAGR of 12% in the forecast period 2022-2032. Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With …

Bioprocess Technology Market to surpass USD 81.2 Bn by 2031, Says FMI

According to a recent study by Future Market Insights (FMI), the global Bioprocess Technology Market was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031. Technology has always been …

Real-Time E-Healthcare System Market to reach a valuation of US$ 47 Bn by 2027 | FMI

[250 Pages Report] The real-time e-healthcare system market is projected to record a CAGR of 6.9% during the forecast period, up from US$ 29 Bn in 2020 to reach a valuation of US$ 47 Bn by 2027. Real-time e-healthcare system is one of the best ways to keep your health records and track it anytime, without any …

Epiglottitis Treatment Market to expand at a 5% value CAGR by 2032 | FMI

The global epiglottitis treatment market demand is presently valued at around US$ 10 Billion and is forecasted to develop at a CAGR of 4.8% to reach US$ 16 Billion by 2032. Epiglottitis is a bacterial viral infection which results in inflammation and swelling of epiglottis, basically epiglottis is a cartilage structure which located at the back of …

IVD Antibodies Market to reaching a valuation of nearly US$ 77 Bn by 2027

[250 Pages Report] The global IVD antibodies market is expected to grow at a healthy CAGR of around 7% between 2022 and 2032, reaching a valuation of nearly US$ 77 billion by 2027. The rising prevalence of chronic and infectious diseases worldwide, as well as the increasing need for early diagnosis of chronic diseases in order to initiate …

Weight Management Market is expected to garner US$ 725.6 Billion from 2022 to 2032 | FMI

[307 Pages Report] The global weight management market is expected to secure US$ 725.6 Billion while recording a CAGR of 7.7% during the forecast period from 2022 to 2032, according to a recently published market research report by Future Market Insights. Increasing adoption of a sedentary lifestyle is expected to drive the global weight management market. …

HIV Antivirals Market is set to reach a valuation of US$ 30.6 Bn in 2022 | FMI

[300 Pages Report] The global HIV antivirals market is expected to be worth $30.6 billion in 2022, with a CAGR of 4.4 percent during the forecast period (2022-2032). According to a recent study, fixed-dose combinations (FDCs) will account for more than 83 percent of the HIV antivirals market in 2021. According to Future Market Insights, the global HIV …

Hemostatic Gels Market to reach US$ 1.9 Billion by 2032 | FMI

As per Future Market Insights’ latest analysis, the global hemostatic gels market is estimated to reach a valuation of US$ 1 Bn in 2022, with sales projected to grow at a 6.8% CAGR over the forecast period. Against this backdrop, the market size will surpass US$ 1.9 Bn by 2032. Increasing adoption of hemostatic gels during surgical procedures for blood loss management is spurring demand …

Paediatric Spasticity Treatment Market is expected to register a CAGR of 10% from 2022 – 2032

[324 Pages Report] During the forecast period, the paediatric spasticity treatment market is expected to grow at a CAGR of 10%. Rising demand for combination products such as benzodiazepines, imidazole, and gamma-aminobutyric acid analogues is driving the global paediatric spasticity treatment market. Furthermore, demand for paediatric spasticity treatment is increasing as a result of increased awareness and …